Systemic lupus erythematosus and coeliac disease [2]

Lupus

Volumn 13, Issue 3, 2004, Pages 214-

  Courtney, Philip A ^a,c   Patterson, R N ^a   Lee, R J E ^a   McMillan, S A ^b  

^a CRAIGAVON AREA HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PREDNISOLONE;

ANTIBODY TITER; CELIAC DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

EID: 1842731942     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu512xx     Document Type: Letter

References (6)

1. Shamir R, Shoenfield Y, Blank M et al. The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus 2003; 12: 394-399.
2. Lerner A, Blank M, Lahat N, Shoenfeld Y. Increased prevalence of autoantibodies in celiac disease. Dig Dis Sci 1998; 43: 723-726.
3. Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol 1997; 136: 315-318.
4. Johnston SD, Watson RG, McMillan SA, Sloan J, Love AH. Prevalence of celiac disease in Northern Ireland. Lancet 1997; 350: 1370.
5. Gourley IS, Patterson CC, Bell AL. The prevalence of systemic lupus erythematosus in Northern Ireland. Lupus 1997; 6: 399-404.
6. Rensch MJ, Szyjkowski R, Schaffer RT et al. The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus. Am J Gastroenterol 2001; 96: 1113-1115.